Transcat(NASDAQ:TRNS) announced the earnings results for Fiscal Year 2017 and Q1. The results came in during After-hours on Jul 26, 2016. Earnings per share were $0.12.
Transcat (TRNS) made into the market gainers list on Fridays trading session with the shares advancing 0.78% or 0.08 points. Due to strong positive momentum, the stock ended at $10.28, which is also near the day’s high of $10.32. The stock began the session at $10.314 and the volume stood at 1,690 shares. The 52-week high of the shares is $11.85 and the 52 week low is $8.26. The company has a current market capitalization of $72 M and it has 69,83,376 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jun 17, 2016, Charles P Hadeed (Chairman of the Board) sold 840 shares at $10.50 per share price.Also, On May 26, 2016, Carl E Sassano (director) sold 8,800 shares at $9.70 per share price.On May 24, 2016, Michael Tschiderer (CFO) purchased 1,500 shares at $9.62 per share price, according to the Form-4 filing with the securities and exchange commission.
Transcat Inc. provides accredited calibration and compliance services and distributes handheld test measurement and control instrumentation. The Company is focused on providing its services to the life science industries which include pharmaceutical biotechnology medical device manufacturing and other Food and Drug Administration-regulated businesses. It also focuses on other industries and customers which include industrial manufacturing; energy and utility; chemical manufacturing and other industries which require accuracy in their processes and confirmation of the capabilities of their equipment. It operates in two segments: service (Service) and distribution (Distribution). Through the Service segment the Company offers calibration compliance and other complementary services. Through its Distribution segment the Company markets sells and rents national brand instruments to customers globally. Its Distribution segment distributes handheld test and measurement equipment.